Novocure

NVCR NASDAQ
93.72
+3.23
+3.57%
盘后: 93.90 +0.18 +0.19% 19:03 08/16 EDT
开盘
91.24
昨收
90.49
最高
94.55
最低
90.87
成交量
103.89万
成交均量(3M)
78.25万
52周最高
94.55
52周最低
26.02
换手率
1.06%
市值
92.01亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Novocure NVCR股票价格,Novocure股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM) and to advance programs testing of TTFields in multiple solid tumor indications through its clinical pipeline. In addition to its clinical and commercial progress in GBM, it is planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and mesothelioma. TTFields are delivered through a portable, medical device. The complete delivery system, which is designed to allow patients to go about their daily activities while receiving continuous cancer treatment, includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories.
展开 >

最近浏览

名称
价格
涨跌幅